Fashion Targets Breast Cancer Fund
Women in the U.S. are more likely to get breast cancer than any other type of cancer, with 207,000 new diagnoses and 40,000 deaths each year. Early detection and treatment provide the best chance for a cure: five-year survival rates are as high as 86 percent among women diagnosed with early-stage tumors. There are two-and-a-half million survivors of breast cancer in the United States.
Fashion Targets Breast Cancer® (FTBC), a charitable initiative of the Council of Fashion Designers of America/CFDA Foundation started in 1994, marshals the goodwill and services of the fashion industry to raise public awareness and funds for the cause. To date, FTBC has granted nearly $50 million to charities worldwide dealing with breast cancer.
In 2011, the Council of Fashion Designers of America began working with The New York Community Trust to develop a focused grantmaking program for the critical areas of breast cancer screening, treatment, and survival. It established the Fashion Targets Breast Cancer Fund to receive funding from CFDA Foundation fundraising and use the money to make grants to New York City organizations for breast cancer screening, prevention, care, treatment and/or advocacy.
The Fashion Targets Breast Cancer Fund made four grants totaling $180,000 to organizations that are leaders in the field of breast cancer treatment: Maimonides Medical Center ($45,000), SHARE – Self Help for Women with Breast or Ovarian Cancer ($45,000), Ralph Lauren Center for Cancer Care and Prevention ($50,000) and New York Hospital Queens ($40,000). The grants help each of the groups expand their patient navigation and survivor services across New York City to reach a diverse range of patients including poor, minority women.
In 2013, The Trust gave $175,000 in grants; In 2012, The Trust gave $125,000 in grants; and in 2011, $105,000.
Please direct any questions to Irfan Hasan at firstname.lastname@example.org
or 212-686-0010 x573. Proposals to the Fashion Targets Breast Cancer Fund are by invitation only.